Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway.
about
Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertensionDiagnostic tools for hypertension and salt sensitivity testing.Genetics of salt-sensitive hypertension.Renal dopamine receptors, oxidative stress, and hypertension.Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.p47(phox) contributes to albuminuria and kidney fibrosis in mice.Intrarenal dopamine inhibits progression of diabetic nephropathy.Antihypertensive mechanisms of intra-renal dopaminePhysiologic and pathophysiologic roles of cyclooxygenase-2 in the kidneyDopamine, the kidney, and hypertension.Upregulation of renal D5 dopamine receptor ameliorates the hypertension in D3 dopamine receptor-deficient mice.Potential dopamine-1 receptor stimulation in hypertension management.Renalase, hypertension, and kidney - the discussion continues.Dopamine and renal function and blood pressure regulation.Cyclooxygenase metabolites in the kidney.Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model.Changes in extracellular matrix composition regulate cyclooxygenase-2 expression in human mesangial cells.Fatty acid receptor modulator PBI-4050 inhibits kidney fibrosis and improves glycemic control.
P2860
Q27331781-B2EF9597-8020-4F0C-AE77-B9F49D23A416Q30417367-50B2470F-8701-42D0-BEFE-3A7158C252F2Q33603268-F7FF2746-83E8-4EF9-B5F0-7C5BC304706DQ34367267-9DE20C71-C77E-4983-898F-D731627FB9FDQ35572452-0A491774-1DB6-43EE-A4FD-50B2CEC89D1DQ35587361-1F7A83A5-E2B9-4F37-9AC8-CD74CFFDAA8FQ36249732-516C6A0B-375E-48E0-8FA4-C8AC2F101713Q36296904-A98FCEC2-0F50-448B-861C-1930FF2D99C8Q37026066-2EB30DE3-4AE7-4288-A779-8772ABBE476EQ37092215-4B8B9BA1-D4E3-46ED-9632-570746221EEAQ37193713-D068BB22-B856-4CD6-86D7-806E6BDA6607Q37883978-531790DB-6473-4131-A136-CC41764CCB06Q38042591-FDB1CD9D-8F74-4BBD-816B-E6C80BEB2CF9Q38111703-41C86673-A0A6-45F9-8D5C-7244DFDAF1EFQ38111723-09AF872C-243E-45C5-8F4D-E071A805A96AQ47817491-97593322-57A3-4B1B-9BBC-A035A2D5E4ADQ54622127-BD026AB2-027C-4306-8943-D3E74E0053D0Q55317917-C2E00042-0C94-4197-A9BA-37065945176A
P2860
Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Intrarenal dopamine attenuates ...... lary cyclooxygenase 2 pathway.
@en
Intrarenal dopamine attenuates ...... lary cyclooxygenase 2 pathway.
@nl
type
label
Intrarenal dopamine attenuates ...... lary cyclooxygenase 2 pathway.
@en
Intrarenal dopamine attenuates ...... lary cyclooxygenase 2 pathway.
@nl
prefLabel
Intrarenal dopamine attenuates ...... lary cyclooxygenase 2 pathway.
@en
Intrarenal dopamine attenuates ...... lary cyclooxygenase 2 pathway.
@nl
P2093
P2860
P1433
P1476
Intrarenal dopamine attenuates ...... lary cyclooxygenase 2 pathway.
@en
P2093
Ming-Zhi Zhang
Raymond C Harris
P2860
P304
P356
10.1161/HYPERTENSIONAHA.109.137174
P407
P577
2009-09-21T00:00:00Z